CN Patent

CN118891270A — 多酰胺类化合物、其制备方法及其医药用途

Assigned to Nhwa Pharmaceutical Corp · Expires 2024-11-01 · 2y expired

What this patent protects

本发明涉及医药领域，具体涉及式IA、IB和IC所示的合成多酰胺类化合物或其药学上可接受的盐、立体异构体和包含其的组合物，其制备方法，以及在医药领域的应用。

USPTO Abstract

本发明涉及医药领域，具体涉及式IA、IB和IC所示的合成多酰胺类化合物或其药学上可接受的盐、立体异构体和包含其的组合物，其制备方法，以及在医药领域的应用。

Drugs covered by this patent

difelikefalin-acetate (DIFELIKEFALIN ACETATE)

Patent Metadata

Patent number: CN118891270A
Jurisdiction: CN
Classification: —
Expires: 2024-11-01
Drug substance claim: No
Drug product claim: No
Assignee: Nhwa Pharmaceutical Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.